Summary
Further key aspects of the report:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Metabotropic Glutamate Receptor market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Metabotropic Glutamate Receptor market segmented into
mGluR2
mGluR4
mGluR5
Based on the end-use, the global Metabotropic Glutamate Receptor market classified into
Attention Deficit Hyperactivity Disorder
Alzheimer's Disease
Chronic Obstructive Pulmonary Disease
Based on geography, the global Metabotropic Glutamate Receptor market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Addex Therapeutics Ltd
Domain Therapeutics SA
Medgenics
Prexton Therapeutics SA
Taisho Pharmaceutical Holdings
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL METABOTROPIC GLUTAMATE RECEPTOR INDUSTRY
2.1 Summary about Metabotropic Glutamate Receptor Industry
2.2 Metabotropic Glutamate Receptor Market Trends
2.2.1 Metabotropic Glutamate Receptor Production & Consumption Trends
2.2.2 Metabotropic Glutamate Receptor Demand Structure Trends
2.3 Metabotropic Glutamate Receptor Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 mGluR2
4.2.2 mGluR4
4.2.3 mGluR5
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Attention Deficit Hyperactivity Disorder
4.3.2 Alzheimer's Disease
4.3.3 Chronic Obstructive Pulmonary Disease
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 mGluR2
5.2.2 mGluR4
5.2.3 mGluR5
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Attention Deficit Hyperactivity Disorder
5.3.2 Alzheimer's Disease
5.3.3 Chronic Obstructive Pulmonary Disease
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 mGluR2
6.2.2 mGluR4
6.2.3 mGluR5
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Attention Deficit Hyperactivity Disorder
6.3.2 Alzheimer's Disease
6.3.3 Chronic Obstructive Pulmonary Disease
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 mGluR2
7.2.2 mGluR4
7.2.3 mGluR5
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Attention Deficit Hyperactivity Disorder
7.3.2 Alzheimer's Disease
7.3.3 Chronic Obstructive Pulmonary Disease
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 mGluR2
8.2.2 mGluR4
8.2.3 mGluR5
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Attention Deficit Hyperactivity Disorder
8.3.2 Alzheimer's Disease
8.3.3 Chronic Obstructive Pulmonary Disease
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 mGluR2
9.2.2 mGluR4
9.2.3 mGluR5
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Attention Deficit Hyperactivity Disorder
9.3.2 Alzheimer's Disease
9.3.3 Chronic Obstructive Pulmonary Disease
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Addex Therapeutics Ltd
10.1.2 Domain Therapeutics SA
10.1.3 Medgenics
10.1.4 Prexton Therapeutics SA
10.1.5 Taisho Pharmaceutical Holdings
10.2 Metabotropic Glutamate Receptor Sales Date of Major Players (2017-2020e)
10.2.1 Addex Therapeutics Ltd
10.2.2 Domain Therapeutics SA
10.2.3 Medgenics
10.2.4 Prexton Therapeutics SA
10.2.5 Taisho Pharmaceutical Holdings
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Metabotropic Glutamate Receptor Product Type Overview
Table Metabotropic Glutamate Receptor Product Type Market Share List
Table Metabotropic Glutamate Receptor Product Type of Major Players
Table Brief Introduction of Addex Therapeutics Ltd
Table Brief Introduction of Domain Therapeutics SA
Table Brief Introduction of Medgenics
Table Brief Introduction of Prexton Therapeutics SA
Table Brief Introduction of Taisho Pharmaceutical Holdings
Table Products & Services of Addex Therapeutics Ltd
Table Products & Services of Domain Therapeutics SA
Table Products & Services of Medgenics
Table Products & Services of Prexton Therapeutics SA
Table Products & Services of Taisho Pharmaceutical Holdings
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Metabotropic Glutamate Receptor Market Forecast (Million USD) by Region 2021f-2026f
Table Global Metabotropic Glutamate Receptor Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Metabotropic Glutamate Receptor Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Metabotropic Glutamate Receptor Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Metabotropic Glutamate Receptor Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Metabotropic Glutamate Receptor Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Metabotropic Glutamate Receptor Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Metabotropic Glutamate Receptor Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Metabotropic Glutamate Receptor Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Metabotropic Glutamate Receptor Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Metabotropic Glutamate Receptor Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR2 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attention Deficit Hyperactivity Disorder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Alzheimer's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Obstructive Pulmonary Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR2 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attention Deficit Hyperactivity Disorder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Alzheimer's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Obstructive Pulmonary Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR2 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attention Deficit Hyperactivity Disorder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Alzheimer's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Obstructive Pulmonary Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR2 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attention Deficit Hyperactivity Disorder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Alzheimer's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Obstructive Pulmonary Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR2 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attention Deficit Hyperactivity Disorder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Alzheimer's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Obstructive Pulmonary Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR2 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR4 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure mGluR5 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Attention Deficit Hyperactivity Disorder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Alzheimer's Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Obstructive Pulmonary Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Metabotropic Glutamate Receptor Sales Revenue (Million USD) of Addex Therapeutics Ltd 2017-2020e
Figure Metabotropic Glutamate Receptor Sales Revenue (Million USD) of Domain Therapeutics SA 2017-2020e
Figure Metabotropic Glutamate Receptor Sales Revenue (Million USD) of Medgenics 2017-2020e
Figure Metabotropic Glutamate Receptor Sales Revenue (Million USD) of Prexton Therapeutics SA 2017-2020e
Figure Metabotropic Glutamate Receptor Sales Revenue (Million USD) of Taisho Pharmaceutical Holdings 2017-2020e